Buy & Sell Novo Nordisk A/S (NVO) – Novo Nordisk A/S Price Today
Key Stats
- $163.08BMarket Cap
- HealthSector
- -44.84%3M Drawdown
- $179.21BEnterprise Value
- 4.87%Dividend Yield
- 97 daysTypical Hold Time
Novo Nordisk A/S (NVO) is currently valued at a market capitalization of $163.08B, with an enterprise value of $179.21B. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $81.05, highlighting its annual price range. Over the past three months, Novo Nordisk A/S has recorded a drawdown of -44.84%, reflecting recent price volatility. Novo Nordisk A/S offers a dividend yield of 4.87%, with the most recent dividend of $1.28 paid on 30 Mar 26. On average, investors hold Novo Nordisk A/S for approximately 97 days, indicating typical investor behavior on the platform.
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
